戻る Agenda
Session 2: Regulatory Dynamics and Future Vision across the Region
Session Chair(s)
Peter J. Pitts
President
Center for Medicine in the Public Interest (CMPI), United States
Rasha Ziada
EDA Chairman Assistant for Technical Development & Capacity Building Affairs
EDA, Egypt
During this session, we will discuss the region’s regulatory dynamics and future trends. The regulatory environment has been fast evolving in the past few years, with a great number of changes across region. The Health Authorities (HAs) are looking into reforms and to adapting to the recent novelties in regulatory affairs, accelerated pathways, variation guidance, roadmaps and digitalisation. In this session, the region’s HAs will be providing their insights, present and future vision, through a brief presentation followed by an interactive Panel Discussion with Q&A.
Speaker(s)
Sabah Memon
National Health Regulatory Authority (NHRA), Bahrain
Senior Pharmacist
Hajed M.H Hashan
Gulf Health Council, Saudi Arabia
Deputy of General Director
Wesal Al Haqish
Jordan Food and Drug Administration (JFDA), Jordan
Drug Directorate Director
Sarah Al Maqseed
Ministry of Health, Kuwait, Kuwait
Registration and Release Superintendent
Dr. Mohammed Hamdan Al Rubaie, PhD, MSc
Ministry of Health, Oman
Directorate General of Pharmaceutical Affairs and Drug Control
Adel A. Al Harf, PhD
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Executive Vice President for Drug Sector